MxBiodevices Company
![](/storage/logos_100px/MxBiodevices.jpg)
Mx Biodevices develops and commercializes an injectable nanoscaffold for the treatment of diabetic foot ulcers and other chronic wounds.
Technology:
Digital Healthcare
Industry:
Telemedicine
Headquarters:
Greenville, North Carolina, United States
Founded Date:
2009
Employees Number:
1-10
Funding Status:
Seed
Total Funding:
$210K
Estimated Revenue:
$1M to $10M
Last Funding Type:
Seed
Register and Claim Ownership